Serum Institute Awaiting Gavi Push For $2 Pneumococcal Vaccine

Pricing Comes Close To MSF’s $5 A Course Target

 
• By Vibha Ravi
Vaccination
Serum First Indian Company To Develop Pneumococcal Vaccine • Source: Shutterstock

More from Business

More from Scrip